Literature DB >> 27585937

Association between DPP4 gene polymorphism and serum lipid levels in Chinese type 2 diabetes individuals.

Xiaomin Xing1, Yi Han2, Xiaojun Zhou3, Bo Zhang4, Yan Li2, Zhongsu Wang5, Lin Liao6, Lequn Su7.   

Abstract

OBJECTIVE: The goal of the genetic investigation was to identify the associations of serum lipid levels and DPP-4 variants in Chinese type 2 diabetes patients.
METHODS: We detected four variants of the DPP4 gene in 190 Chinese individuals with type 2 diabetes and tested for an association with dyslipidemia in 82 selected samples. Data including basic information, HbA1c, FPG, serum lipid parameters were collected. Statistical analysis was performed by SPSS 13.0 through ANOVA and χ2 test.
RESULTS: The genetic polymorphism of rs4664443, rs3788979, rs7608798 and rs1558957 in Chinese type 2 diabetes were consistent with Hardy-Weinberg equilibrium. The CT genotype of rs4664443 suffered from higher serum TG (P=0.013), LDL (P=0.044) and ApoB (P=0.006) levels, whereas the TT genotype of rs7608798 exhibited a lower serum TG level (P=0.037). For rs3788979, the serum TG level (P=0.034) and BMI (P=0.04) were significantly different among genotypes. Moreover, serum TG and TC levels and BMI showed a positive correlation with the number unfavorable alleles, and individuals with more than two unfavorable alleles had higher TG (P=0.004), TC (P=0.011), and BMI (P=0.044) values.
CONCLUSIONS: This is the first study to investigate DPP4 allelic distributions and their association with dyslipidemia in Chinese type 2 diabetes patients, which may have clinical significance.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DPP4; Polymorphism; Serum lipid levels; Type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27585937     DOI: 10.1016/j.npep.2016.08.005

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  8 in total

Review 1.  DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.

Authors:  Chayakrit Krittanawong; Andrew Xanthopoulos; Takeshi Kitai; Natalia Branis; HongJu Zhang; Marrick Kukin
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

2.  Association of dipeptidyl peptidase IV polymorphism, serum lipid profile, and coronary artery stenosis in patients with coronary artery disease and type 2 diabetes.

Authors:  Zhongsu Wang; Yang Liu; Weizong Wang; Haiyan Qu; Yi Han; Yinglong Hou
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

3.  Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion.

Authors:  Rita S Patarrão; Nádia Duarte; Inês Coelho; Joey Ward; Rogério T Ribeiro; Maria João Meneses; Rita Andrade; João Costa; Isabel Correia; José Manuel Boavida; Rui Duarte; Luís Gardete-Correia; José Luís Medina; Jill Pell; John Petrie; João F Raposo; Maria Paula Macedo; Carlos Penha-Gonçalves
Journal:  Diabetologia       Date:  2022-02-22       Impact factor: 10.122

Review 4.  DPP4 as a Potential Candidate in Cardiovascular Disease.

Authors:  Si-Yu Chen; Xiang-Quan Kong; Ke-Fan Zhang; Shuai Luo; Feng Wang; Jun-Jie Zhang
Journal:  J Inflamm Res       Date:  2022-09-16

5.  Genetic variation in DPP-IV gene linked to predisposition of T2DM: A case control study.

Authors:  Archna Bhargave; Kiran Devi; Imteyaz Ahmad; Anita Yadav; Ranjan Gupta
Journal:  J Diabetes Metab Disord       Date:  2022-10-12

6.  A haplotype in the dipeptidyl peptidase 4 gene impacts glycemic-related traits of Brazilian older adults.

Authors:  E S Alves; A C Tonet-Furioso; V P Alves; C F Moraes; D I V Pérez; I M D Bastos; C Córdova; O T Nóbrega
Journal:  Braz J Med Biol Res       Date:  2022-10-03       Impact factor: 2.904

7.  The rs12617336 and rs17574 Dipeptidyl Peptidase-4 Polymorphisms Are Associated With Hypoalphalipoproteinemia and Dipeptidyl Peptidase-4 Serum Levels: A Case-Control Study of the Genetics of Atherosclerotic Disease (GEA) Cohort.

Authors:  Gilberto Vargas-Alarcón; María Del Carmen González-Salazar; Christian Vázquez-Vázquez; Adrián Hernández-Díaz Couder; Fausto Sánchez-Muñoz; Juan Reyes-Barrera; Sergio A Criales-Vera; Marco Sánchez-Guerra; Citlalli Osorio-Yáñez; Rosalinda Posadas-Sánchez
Journal:  Front Genet       Date:  2021-06-11       Impact factor: 4.599

8.  Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus.

Authors:  Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Alexander Prokscha; Hassan Y Naim; Marcel A Müller; Christian Drosten; Stefan Pöhlmann; Markus Hoffmann
Journal:  Emerg Microbes Infect       Date:  2020-01-21       Impact factor: 7.163

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.